Cofoe Medical Technology Co Ltd
SZSE:301087

Watchlist Manager
Cofoe Medical Technology Co Ltd Logo
Cofoe Medical Technology Co Ltd
SZSE:301087
Watchlist
Price: 55.56 CNY 2.17% Market Closed
Market Cap: ¥11.6B

Income Statement

Earnings Waterfall
Cofoe Medical Technology Co Ltd

Income Statement
Cofoe Medical Technology Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Revenue
Interest Expense
1
3
4
7
8
11
11
11
11
13
0
14
15
15
20
18
18
0
0
Revenue
3 023
N/A
2 246
-26%
2 331
+4%
2 276
-2%
2 229
-2%
2 472
+11%
2 456
-1%
2 977
+21%
3 232
+9%
3 200
-1%
3 223
+1%
2 854
-11%
2 805
-2%
2 893
+3%
2 978
+3%
2 983
+0%
2 914
-2%
2 920
+0%
3 132
+7%
Gross Profit
Cost of Revenue
(1 650)
(1 228)
(1 249)
(1 296)
(1 302)
(1 525)
(1 569)
(1 839)
(1 872)
(1 848)
(1 832)
(1 670)
(1 635)
(1 599)
(1 578)
(1 468)
(1 411)
(1 407)
(1 494)
Gross Profit
1 373
N/A
1 018
-26%
1 083
+6%
980
-10%
927
-5%
947
+2%
887
-6%
1 137
+28%
1 359
+19%
1 353
0%
1 391
+3%
1 184
-15%
1 170
-1%
1 294
+11%
1 401
+8%
1 515
+8%
1 503
-1%
1 513
+1%
1 638
+8%
Operating Income
Operating Expenses
(713)
(582)
(606)
(482)
(541)
(600)
(626)
(865)
(999)
(993)
(1 026)
(961)
(981)
(1 081)
(1 145)
(1 194)
(1 196)
(1 212)
(1 309)
Selling, General & Administrative
(689)
(568)
(576)
(454)
(528)
(570)
(597)
(712)
(826)
(821)
(844)
(789)
(874)
(972)
(1 051)
(1 010)
(1 120)
(1 131)
(1 229)
Research & Development
(56)
(57)
(65)
(67)
(80)
(91)
(95)
(110)
(127)
(127)
(127)
(104)
(107)
(105)
(104)
(91)
(93)
(91)
(88)
Depreciation & Amortization
0
0
0
(50)
0
0
0
(72)
0
0
0
(102)
0
0
0
(122)
0
0
0
Other Operating Expenses
32
42
36
89
67
61
65
29
(45)
(46)
(55)
35
0
(5)
11
28
16
10
8
Operating Income
660
N/A
436
-34%
477
+9%
497
+4%
386
-22%
346
-10%
261
-25%
273
+5%
360
+32%
360
0%
365
+2%
223
-39%
189
-15%
213
+13%
256
+20%
321
+25%
307
-4%
301
-2%
329
+9%
Pre-Tax Income
Interest Income Expense
4
3
1
13
23
57
73
97
100
82
83
63
63
59
53
47
51
50
46
Non-Reccuring Items
0
0
0
0
0
1
3
(29)
7
8
8
8
5
2
(0)
5
6
5
5
Total Other Income
(3)
(1)
(2)
(3)
(3)
(4)
(4)
(6)
(35)
(36)
(36)
(8)
(8)
(4)
(4)
(1)
(1)
(0)
1
Pre-Tax Income
661
N/A
438
-34%
476
+9%
508
+7%
406
-20%
400
-2%
334
-16%
334
+0%
431
+29%
414
-4%
420
+2%
286
-32%
249
-13%
271
+9%
304
+12%
372
+22%
363
-3%
356
-2%
381
+7%
Net Income
Tax Provision
(106)
(71)
(79)
(79)
(54)
(54)
(40)
(32)
(48)
(44)
(45)
(33)
(28)
(33)
(42)
(60)
(60)
(61)
(61)
Income from Continuing Operations
555
367
397
430
352
346
294
302
383
370
375
253
221
238
262
312
303
294
320
Income to Minority Interest
(1)
(1)
(0)
(1)
(3)
(2)
(2)
(0)
3
1
1
1
0
3
2
(1)
(1)
(0)
0
Net Income (Common)
462
N/A
274
-41%
304
+11%
429
+41%
349
-19%
343
-1%
292
-15%
302
+3%
386
+28%
370
-4%
376
+2%
254
-32%
221
-13%
240
+9%
264
+10%
312
+18%
302
-3%
294
-3%
320
+9%
EPS (Diluted)
2.21
N/A
1.31
-41%
5.92
+352%
2.61
-56%
1.67
-36%
1.63
-2%
1.4
-14%
1.45
+4%
1.87
+29%
1.76
-6%
1.82
+3%
1.24
-32%
1.07
-14%
1.17
+9%
1.29
+10%
1.51
+17%
1.48
-2%
1.44
-3%
1.57
+9%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett